Workshop and Q&A October 6th

Strain identifier

BacDive ID: 2631

Type strain: Yes

Species: Clostridium perfringens

Strain Designation: S107

Culture col. no.: DSM 756, ATCC 13124, ATCC 19408, NCIB 6125, NCTC 6125, NCTC 8237, WDCM 00007, CCUG 1795, CIP 103409, JCM 1290, BCRC 10913, CCM 4435, CECT 376, KCTC 3269, LMG 11264, NCIMB 6125

Strain history: ATCC 13124 <-- NCTC 8237 ("Clostridium welchii") <-- Wellcome Lab.; CN 1491.

NCBI tax ID(s): 195103 (strain), 1502 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Clostridium perfringens S107 is an anaerobe, mesophilic human pathogen that produces toxins and was isolated from bovine.

  1. toxin production
  2. anaerobe
  3. human pathogen
  4. mesophilic
  5. 16S sequence
  6. Bacteria
  7. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #428] Culture collection no. DSM 756, ATCC 13124, ATCC 19408, NCIB 6125, NCTC 6125, NCTC 8237, WDCM 00007, CCUG 1795, CIP 103409, JCM 1290, BCRC 10913, CCM 4435, CECT 376, KCTC 3269, LMG 11264, NCIMB 6125
    [Ref.: #20218] Associated Passport(s) in StrainInfo 7948, 7940, 7941, 7951, 7952, 7953, 866259
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort Mesharrow to sort Topicarrow to sort Topic2arrow to sort
    Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. Mollby R, Holme T, Nord CE, Smyth CJ, Wadstrom T J Gen Microbiol 10.1099/00221287-96-1-137 1976 Abdominal Injuries/microbiology, Clostridium Infections/microbiology, Clostridium perfringens/classification/growth & development/*metabolism, Feces/microbiology, Gas Gangrene/microbiology, Hemolysin Proteins/*biosynthesis, Humans, Hydrogen-Ion Concentration, Phospholipases/*biosynthesis, Serotyping, Species Specificity, Toxins, Biological/*biosynthesis Pathogenicity Phylogeny *
    Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Sutter VL, Barry AL, Wilkins TD, Zabransky RJ Antimicrob Agents Chemother 10.1128/AAC.16.4.495 1979 Anaerobiosis, Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects, Culture Media, Evaluation Studies as Topic, Microbial Sensitivity Tests/*methods Cultivation Pathogenicity *
    Collagenase of Clostridium perfringens type A: degradation of human complement component C1q. Wolf U, Bauer D, Traub WH Zentralbl Bakteriol 10.1016/s0934-8840(11)80215-x 1991 Blotting, Western, Clostridium perfringens/*enzymology, Complement C1q/*metabolism, Electrophoresis, Polyacrylamide Gel, Humans, Isoelectric Point, Microbial Collagenase/chemistry/isolation & purification/*metabolism, Molecular Weight Enzymology Metabolism *
    Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem. Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA J Clin Microbiol 10.1128/jcm.28.12.2804-2805.1990 1990 Bacteria, Anaerobic/*drug effects, Meropenem, Microbial Sensitivity Tests/methods/*standards, Quality Control, Reference Values, Thienamycins/*pharmacology Pathogenicity *
    Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria. Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RN J Clin Microbiol 10.1128/jcm.27.1.190-191.1989 1989 Bacteria, Anaerobic/*drug effects, Cefotetan/*pharmacology, Microbial Sensitivity Tests/*standards, Multicenter Studies as Topic, Quality Control, Reference Values Pathogenicity *
    Effect of antibiotics on toxin production and viability of Clostridium perfringens. Stevens DL, Maier KA, Mitten JE Antimicrob Agents Chemother 10.1128/AAC.31.2.213 1987 Anti-Bacterial Agents/*pharmacology, Bacterial Toxins/*biosynthesis, *Calcium-Binding Proteins, Cefoxitin/pharmacology, Chloramphenicol/pharmacology, Clindamycin/pharmacology, Clostridium perfringens/*drug effects/growth & development/metabolism, Kinetics, Metronidazole/pharmacology, Microbial Sensitivity Tests, Penicillin G/pharmacology, Rifampin/pharmacology, Tetracycline/pharmacology, *Type C Phospholipases Pathogenicity Enzymology *
    Evaluation of some commercial media for the cultivation and enumeration of Clostridium perfringens from the chick intestine. Dafwang II, Ricke SC, Schaefer DM, Brotz PG, Sunde ML, Pringle DJ Poult Sci 10.3382/ps.0660652 1987 Animals, Chickens/*microbiology, Clostridium perfringens/growth & development/*isolation & purification, Culture Media, Intestines/*microbiology Cultivation Enzymology *
    Growth curves of Clostridium perfringens in Schaedler and brain heart infusion broths. Traub WH, Spohr M, Bauer D Zentralbl Bakteriol Mikrobiol Hyg A 10.1016/s0176-6724(87)80035-4 1987 Animals, Clostridium perfringens/*growth & development/pathogenicity, Culture Media, Humans, Mice, Virulence Cultivation Pathogenicity *
    Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product. Tweten RK Infect Immun 10.1128/iai.56.12.3228-3234.1988 1988 Amino Acid Sequence, Bacterial Toxins/*genetics/metabolism, Cloning, Molecular, Clostridium perfringens/*genetics, Escherichia coli/genetics/metabolism, Genes, Bacterial, Hemolysin Proteins, Hemolysis, Molecular Sequence Data, Molecular Weight, Peptide Mapping, Recombinant Proteins/genetics, Restriction Mapping Enzymology Metabolism *
    Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase. Malouin F, Fijalkowski C, Lamothe F, Lacroix JM Antimicrob Agents Chemother 10.1128/AAC.30.5.749 1986 Bacteroides/*enzymology, Biological Assay, Cefoxitin/*antagonists & inhibitors/pharmacology, Hydrolysis, Microbial Sensitivity Tests, Moxalactam/*antagonists & inhibitors/pharmacology, Spectrophotometry, Ultraviolet, beta-Lactamases/*pharmacology Enzymology *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:

CAPTCHAReload captcha

Change proposal

Successfully sent